JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB273298

Advanced Glycation End Products (AGEs) Assay Kit

Be the first to review this product! Submit a review

|

(5 Publications)

Advanced Glycation End Products (AGEs) Activity Assay Kit (ab273298) can be used for the semi-quantitative estimation of fluorescent AGEs levels in Biological Fluids.
2 Images
Functional Studies - Advanced Glycation End Products (AGEs) Assay Kit (AB273298)
  • FuncS

Supplier Data

Functional Studies - Advanced Glycation End Products (AGEs) Assay Kit (AB273298)

AGE and BSA standard curve.

Typical standard curve – data provided for demonstration purposes only. A new standard curve must be generated for each assay performed.

AGEs-Positive (AGE-BSA) fluorescence versus BSA. The assay can distinguish both species (AGEs and non-oxidized proteins).

Functional Studies - Advanced Glycation End Products (AGEs) Assay Kit (AB273298)
  • FuncS

Supplier Data

Functional Studies - Advanced Glycation End Products (AGEs) Assay Kit (AB273298)

AGE activity in serum samples.

AGEs amount in Pooled Human Serum from healthy donors (4 μg serum protein), Human Diabetic Serum (4 μg serum protein) and Human Urine from healthy donor.

Key facts

Detection method

Fluorescent

Sample types

Serum, Urine

Results type

Semi-Quantitative

Assay Platform

Microplate

Product details

Advanced Glycation End Products (AGEs) Activity Assay Kit (ab273298) can be used for the semi-quantitative estimation of fluorescent AGEs levels in Biological Fluids. The assay is based on the characteristic fluorescence (Ex/Em= 360/460 nm), a characteristic that is shared by almost all AGEs. The proprietary composition of the Assay Buffer specifically distinguishes between AGEs and non-oxidized proteins. The one-step assay uses oxidized Bovine Serum Albumin (AGE-BSA) as a Positive Control. BSA is used as Background Control and its fluorescence under assay conditions is defined as 1 relative fluorescence intensity in arbitrary units (AU or RFUSample/ RFUBackground).

This product is manufactured by BioVision, an Abcam company and was previously called K929 Advanced Glycation End Products (AGEs) Assay Kit. K929-100 is the same size as the 100 test size of ab273298.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

What's included?

{ "values": { "100Test": { "sellingSize": "100 Test", "publicAssetCode":"ab273298-100Test", "assetComponentDetails": [ { "size":"1 x 500 µL", "name":"Positive Control Protein", "number":"AB273298-CMP02", "productcode":"" }, { "size":"1 x 50 mL", "name":"Wash Buffer II", "number":"AB273298-CMP01", "productcode":"" }, { "size":"1 x 500 µL", "name":"BSA Standard I", "number":"AB273298-CMP03", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Advanced Glycation End-products (AGEs) are highly reactive compounds formed when reducing sugars non-enzymatically bind to proteins lipids or nucleic acids. They are often referred to as AGE products or AGE-BSA when in the form of bovine serum albumin (BSA). The molecular weight of AGE compounds can vary significantly due to the diversity of glycation products. AGEs express in various tissues but accumulate more in aging tissues and in certain pathological states. Detection of AGE products often utilizes AGE ELISA assays or fluorescence-based methods to measure AGE-BSA.
Biological function summary

AGE compounds affect cellular and tissue functions by altering structural proteins and increasing oxidative stress. While not a component of a specific complex AGEs catalyze cross-linking of proteins like collagen impacting tissue elasticity. The binding of AGEs to receptors such as RAGE (Receptor for Advanced Glycation End-products) triggers inflammatory pathways and oxidative stress. This interaction fuels the damaging effects of AGEs in biological systems which are assayed through AGE assays.

Pathways

AGE compounds influence several critical biological pathways particularly the NF-kB and MAPK pathways. These pathways mediate inflammation and cellular stress responses. The interaction with RAGE also affects signaling with related proteins like S100/calgranulins which further activate pro-inflammatory responses. The alteration of these pathways by AGE compounds highlights their significance in cellular dysfunction and age-related conditions.

AGE compounds play significant roles in the progression of diabetes and cardiovascular disease. In diabetes AGEs contribute to complications by modifying vascular structure and function where they link with proteins such as HbA1c in glycation. In cardiovascular disease AGE accumulation in vascular tissues enhances vascular stiffness and atherosclerotic lesion formation. The AGE-RAGE interaction perpetuates chronic inflammation further exacerbating these conditions.

Product protocols

Publications (5)

Recent publications for all applications. Explore the full list and refine your search

Medicina (Kaunas, Lithuania) 61: PubMed40572656

2025

Salivary 1,5-Anhydroglucitol and AGEs Are Associated with Postural Instability in Diabetic Foot Patients.

Applications

Unspecified application

Species

Unspecified reactive species

Lorenzo Brognara,Mar Sempere-Bigorra,Omar Cauli

Nutrients 16: PubMed39339746

2024

Botanical Bioflavonoid Composition from - and -Protected Mice against D-Galactose-Induced Immunosenescence, and Cyclophosphamide Induced Immune Suppression.

Applications

Unspecified application

Species

Unspecified reactive species

Mesfin Yimam,Teresa Horm,Alexandria O'Neal,Paola Chua,Ping Jiao,Mei Hong,Qi Jia

BMC complementary medicine and therapies 24:225 PubMed38858747

2024

Ge-Gen-Qin-Lian decoction alleviates the symptoms of type 2 diabetes mellitus with inflammatory bowel disease via regulating the AGE-RAGE pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Zhipeng Li,Ziwei Zhao,Shujuan Chen,Xiaojuan Wang,Dongsheng Wang,Xiaoli Nie,Ye Yao

BMC cardiovascular disorders 23:446 PubMed37697234

2023

Sodium tanshinone IIA sulfonate ameliorates neointima by protecting endothelial progenitor cells in diabetic mice.

Applications

Unspecified application

Species

Unspecified reactive species

Yan-Yan Heng,Hui-Juan Shang,Xia-Ze Zhang,Wei Wei

International journal of molecular sciences 24: PubMed36675183

2023

ATF3/SPI1/SLC31A1 Signaling Promotes Cuproptosis Induced by Advanced Glycosylation End Products in Diabetic Myocardial Injury.

Applications

Unspecified application

Species

Unspecified reactive species

Shengqi Huo,Qian Wang,Wei Shi,Lulu Peng,Yue Jiang,Mengying Zhu,Junyi Guo,Dewei Peng,Moran Wang,Lintong Men,Bingyu Huang,Jiagao Lv,Li Lin
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com